Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Bostom

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Biochemical Society Transactions|August 1, 1995
Renal metabolism of homocysteine in vivoJ T Brosnan, B Hall, J Selhub, et al.
Atherosclerosis|August 1, 1993
Elevations in total plasma homocysteine in premature coronary artery, cerebrovascular and peripheral vascular diseaseA G Bostom, C B Eaton, L Yanek, et al.
Atherosclerosis|February 27, 2001
Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination SurveyM S Morris, A G Bostom, P F Jacques, et al.
Public Health Reviews|June 20, 2001
Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortificationJ Selhub, P F Jacques, A G Bostom, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 28, 2000
Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutritionD Shemin, A G Bostom, C Lambert, et al.
The New England Journal of Medicine|May 13, 1999
The effect of folic acid fortification on plasma folate and total homocysteine concentrationsP F Jacques, J Selhub, A G Bostom, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 1999
Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinineA G Bostom, L Bausserman, P F Jacques, et al.
Atherosclerosis|February 1, 1996
Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patientsA G Bostom, D Shemin, D Yoburn, et al.
Kidney International|January 3, 2001
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patientsA Yango, D Shemin, N Hsu, et al.
Journal of the American Society of Nephrology : JASN|May 8, 1999
Plasma total homocysteine and hemodialysis access thrombosis: a prospective studyD Shemin, K L Lapane, L Bausserman, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Biochemical Society Transactions|August 1, 1995
Renal metabolism of homocysteine in vivoJ T Brosnan, B Hall, J Selhub, et al.
Atherosclerosis|August 1, 1993
Elevations in total plasma homocysteine in premature coronary artery, cerebrovascular and peripheral vascular diseaseA G Bostom, C B Eaton, L Yanek, et al.
Atherosclerosis|February 27, 2001
Hyperhomocysteinemia and hypercholesterolemia associated with hypothyroidism in the third US National Health and Nutrition Examination SurveyM S Morris, A G Bostom, P F Jacques, et al.
Public Health Reviews|June 20, 2001
Relationship between plasma homocysteine and vitamin status in the Framingham study population. Impact of folic acid fortificationJ Selhub, P F Jacques, A G Bostom, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 28, 2000
Residual renal function in a large cohort of peritoneal dialysis patients: change over time, impact on mortality and nutritionD Shemin, A G Bostom, C Lambert, et al.
The New England Journal of Medicine|May 13, 1999
The effect of folic acid fortification on plasma folate and total homocysteine concentrationsP F Jacques, J Selhub, A G Bostom, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 10, 1999
Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinineA G Bostom, L Bausserman, P F Jacques, et al.
Atherosclerosis|February 1, 1996
Lack of effect of oral N-acetylcysteine on the acute dialysis-related lowering of total plasma homocysteine in hemodialysis patientsA G Bostom, D Shemin, D Yoburn, et al.
Kidney International|January 3, 2001
Rapid communication: L-folinic acid versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patientsA Yango, D Shemin, N Hsu, et al.
Journal of the American Society of Nephrology : JASN|May 8, 1999
Plasma total homocysteine and hemodialysis access thrombosis: a prospective studyD Shemin, K L Lapane, L Bausserman, et al.
Pageof 7